Stephanie Marie Fawcett, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1010 East St, Tonganoxie, KS 66086 Phone: 913-369-8705 |
Physical Therapy Solutions Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 1198 Front St, Tonganoxie, KS 66086 Phone: 913-369-0022 Fax: 913-369-2836 |
Marty Catherine Brown, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1198 Front St, Tonganoxie, KS 66086 Phone: 913-845-2252 Fax: 913-845-2262 |
Ryan David West, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1198 Front St, Tonganoxie, KS 66086 Phone: 913-417-7400 Fax: 913-369-2836 |
Dr. Narendra Dattatraya Saraf, DPT,MS,PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 W 8th St, Tonganoxie, KS 66086 Phone: 913-845-2204 |
News Archive
In a major scientific study published in the journal Cell, scientists at the UNC School of Medicine and the UNC Gillings School of Global Public Health have characterized the specific ways in which SARS-CoV-2 – the coronavirus that causes COVID-19 – infects the nasal cavity to a great degree – replicating specific cell types – and infects and replicates progressively less well in cells lower down the respiratory tract, including the lungs.
Data from additional years of follow-up of a large randomized placebo-controlled clinical trial of tamoxifen for the prevention of breast cancer confirm that the drug reduces the risk of invasive and noninvasive breast cancer, according to a report that appears in the current issue of the Journal of the National Cancer Institute.
Mental illness of a family member destroys the family's connection with the religious community, a new study by Baylor University psychologists has found, leading many affected families to leave the church and their faith behind.
Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee voted today to recommend non-approval of liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT), currently under FDA review for the treatment of exocrine pancreatic insufficiency (EPI).
Doctors have developed a new five-minute procedure to scan the blood vessels which offers hope for claustrophobic patients unable to tolerate the conventional longer test. The research is presented today at CMR 2018.
› Verified 7 days ago